Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF433 and ZNF878 antisense RNA 1 (ZNF433-AS1)
- Target
- ZNF433-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA, Other
01
Overview
ZNF433-AS1 is a long non-coding antisense RNA gene that overlaps the ZNF433 and ZNF878 loci. Its presumed primary molecular function is the regulation of the expression of its sense-strand gene counterparts, ZNF433 and ZNF878, both of which are KRAB domain-containing zinc finger proteins potentially involved in transcriptional regulation and tumor suppression. There is currently no direct evidence linking ZNF433-AS1 to human disease or therapeutic intervention. Its functional role is inferred from the general properties of antisense RNAs, which typicaly modulate gene expression by binding to complementary mRNAs.
- Other names
- ZNF433-AS1
02
Mechanism of action
Not applicable, as no drugs interact with this RNA.
03
Biological functions
Regulation of sense-strand gene expression (specifically ZNF433 and ZNF878)Likely involvement in transcriptional regulation via RNA interaction (as typical of antisense RNAs)
04
Disease associations
No direct disease role is reported for ZNF433-AS1. However, its sense-strand targets (ZNF433) have roles in cancer biology, particularly as potential tumor suppressors in clear-cell renal cell carcinoma. The antisense RNA's potential implication is unknown but may be indirect via its effect on ZNF433.
05
Safety considerations
Not applicable; no therapeutics are currently known to target ZNF433-AS1.
06
Interacting drugs
None reported. There are currently no drugs targeting ZNF433-AS1 itself.
07
Biomarkers
None documented for ZNF433-AS1 itself; however, sense-gene ZNF433's expression and methylation may serve as biomarkers in clear-cell renal cell carcinoma.
Beyond the preview
Go deeper on ZNF433 and ZNF878 antisense RNA 1 (ZNF433-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ZNF433 and ZNF878 antisense RNA 1 (ZNF433-AS1).